Contact this trialFirst, we need to learn more about you.
Chemotherapy
CTO + Temodar® for Glioblastoma
Recruiting2 awardsPhase 1
Portland, Oregon
This trial is testing the safety and effectiveness of a new cancer drug, carboxyamidotriazole orotate (CTO). It will be given alone or in combination with other drugs to patients with brain tumors.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service